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H I G H L I G H T S
• Collateral circulation status and final infarct volume (FIV) are independent outcome predictors after an AIS.• We evaluated the association of statin pretreatment (SP) on collateral circulation and FIV in AIS patients.• SP was associated with lower FIV compared to no SP, especially in atherosclerotic AIS.• A trend towards good collateral scores was observed in the SP group.• SP appears to be associated with decreased FIV after AIS, possibly due to more favorable collateral circulation.
A B S T R A C T
Background and aims: Statin pretreatment (SP) is associated with improved outcomes in acute ischemic stroke (AIS) patients. Collateral circulation status and final
infarct volume (FIV) are independent predictors of functional outcome in AIS.
Methods: We sought to evaluate the association of SP with collateral circulation and FIV in AIS patients. We used a random-effects model for all the analyses, and
pooled standardized mean differences (SMDs) and odds ratios (OR) on the FIV and collateral status according to SP history, respectively.
Results: We identified 9 eligible studies (1186 AIS patients). History of SP was associated with lower FIV (SMD=0.25, 95%CI: 0.07–0.42, p=0.005) compared to
negative history of SP. A trend towards good collateral scores was observed in the SP group (OR=1.45; 95% CI, 0.92–2.29, p=0.11). Subgroup analysis de-
monstrated reduced FIV among atherosclerotic stroke patients with history of SP (SMD=0.49; 95% CI, 0.19–0.80, p=0.001).
Conclusions: SP appears to be associated with decreased FIV, especially in atherosclerotic AIS.
1. Introduction
Statin pretreatment (SP) is associated with favorable clinical
outcomes in acute ischemic stroke (AIS) due to large artery athero-
sclerosis (LAA) [1]. Pleiotropic properties of statins extend beyond lipid
lowering effects, encompassing positive influence on endothelial
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function, cerebral hemodynamics, inflammatory response, platelet
function and lipid oxidation [2]. These tissue-level effects further cor-
respond to atherosclerotic plaque stabilization and reduction in stroke
recurrence [3]. There are preliminary data showing that SP may be
correlated with improved collateralization among AIS patients [4,5].
Moreover, SP have been demonstrated to up-regulate endothelial nitric
oxide synthase (eNOS) activity that further enhances collateral perfu-
sion and reduces final infarct volumes (FIV) [6]. Although improved
collateral circulation results in reduction of FIV and better clinical
outcomes, the potential influence of SP on collateral circulation status
and final infarct size has not been determined. In view of these con-
siderations, we performed a systematic review and meta-analysis of
available studies reporting FIV or collateral grades based on digital
subtraction angiography (DSA) in AIS patients with and without SP.
2. Materials and methods
We adopted the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) guidelines for systematic reviews and
meta-analyses [7]. We used the Newcastle-Ottawa Scale to explore
sources of bias amongst the included observational studies as pre-
viously described [8].
We identified all eligible observational studies that investigated the
association of statin pre-treatment (SP) prior to admission with col-
lateral circulation and core infarct volume. Systematic search was
conducted in Embase/MEDLINE and Scopus databases from inception
to June 17, 2018. Additional manual search included conference ab-
stracts and bibliographies of candidate studies and recent systematic
reviews for a comprehensive literature search. The detailed search
algorithm used on MEDLINE search is outlined in Supplementary
Materials. No language or other restrictions was imposed. All retrieved
studies were independently reviewed by three authors (KM, AS & GT),
with any disagreement resolved by consensus. We excluded case series,
case reports, or studies not reporting any information on SP. In those
studies where the original publication reported evidence of SP strati-
fication, but did not contain all necessary data, we contacted the cor-
responding authors by e-mail. The quality control and bias identifica-
tion were performed independently by 2 reviewers (KM, AHK), and
disagreements, if any, were resolved by a third tie-breaking evaluator
(GT).
The corresponding odds ratios (OR) for good collaterals and stan-
dardized mean differences (SMD) to assess final infarct volumes (FIV) in
patients with SP versus patients without SP were calculated. We also
conducted subgroup analyses to evaluate association of SP and FIV
among patients with different stroke subtypes. We selected those stu-
dies that assessed DSA-based collateral grades according to either the
American Society of Interventional and Therapeutic Neuroradiology/
Society of Interventional Radiology (ASITN/SIR) or collateral pial cir-
culation (CPC) collateral flow grading classifications. We defined good
collaterals as ASITN/SIR grades 3–4 or CPC scores 0–2, as previously
described [2,9]. FIV was defined as infarct regions measured using
ABC/2 method on available neuroimaging during hospitalization [2].
In all analyses, SMDs and ORs of individual studies were pooled
using the random-effects model (DerSimonian Laird). Heterogeneity
between studies was evaluated using Cochran Q and I2 statistics, with I2
values of I2> 50% and I2> 75% indicating substantial and consider-
able heterogeneity, respectively [10]. Publication bias across individual
studies was graphically assessed using a funnel plot, while formal
Fig. 1. Flow-chart diagram presenting the selection of eligible studies.
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assessment with Egger's test could not be performed due to the small
number of studies (< 10 studies). All statistical analyses were con-
ducted using Review Manager (RevMan) Version 5.3 software (Co-
penhagen: The Nordic Cochrane Centre, The Cochrane Collaboration,
2014).
3. Results
The systematic search of Embase/MEDLINE and Scopus databases
yielded 429 and 309 results respectively. After removing duplicates, the
titles and abstracts of the remaining 730 studies were screened and,
from the 16 potentially eligible studies, 7 studies were excluded for lack
of data availability on either collateral scores or infarct volume strati-
fied by SP status (Supplementary Table I). In the final evaluation of the
literature search results, there was no conflict or disagreement between
reviewers and the 9 studies that met the protocol's inclusion criteria
were included in the meta-analysis (Fig. 1) [2,5,6,9,11–15]. The cor-
responding authors from 7 studies [2,6,9,11,12,14,15] were contacted
to obtain necessary unpublished data for the quantitative analyses. Data
on collateral status were available as ASITN/SIR [3,5,9,11,13,14] or
CPC [2] classification, whereas FIV data were available from 6 studies
[2,6,11–14].
The patient data and study protocols of the included studies com-
prising a total of 1186 patients are summarized in Table 1 and
Supplementary Table II. The risk of bias in the included studies was
considered to be moderate, mainly because of the lack of reporting
appropriate adjustments for potential confounders in 4 study protocols
(Supplementary Table III).
SP was associated with reduced FIV on neuroimaging (SMD=0.25;
95% CI, 0.07–0.42; Fig. 2A). In studies reporting on collateral status, a
trend towards good collateral scores was observed in the SP group
(OR=1.45; 95% CI, 0.92–2.29; Fig. 2B). No evidence of heterogeneity
was observed for FIV (I2= 12%, p for Cochran Q statistic= 0.34) or
good collateral status (I2= 34%, p for Cochran Q statistic= 0.17). In-
spection of the funnel plot revealed no evidence of asymmetry
(Supplementary Fig. I and II).
A subgroup analysis comparing stroke subtypes revealed that SP
was associated with reduced FIV among patients with atherosclerotic
strokes (3 studies; SMD=0.49; 95% CI, 0.19–0.80; Fig. 2C). No evi-
dence of heterogeneity was observed (I2 = 0%, p for Cochran Q sta-
tistic= 0.51).
4. Discussion
To the best of our knowledge, this is the first meta-analysis de-
monstrating the beneficial effect of SP among AIS patients in regards to
reduced infarct volume. Prior studies have demonstrated improved
collateral circulation with SP among acute LAA [2] or cardioembolic
strokes [4,5]. These beneficial effects are likely attributed to the po-
tential for statins to promote arteriogenesis and augment the eNOS-
mediated vasodilation [6]. Among AIS patients with symptomatic in-
tracranial atherosclerotic plaques, SP has been associated with reduced
plaque enhancement, stabilization of atherosclerotic plaques, and lower
frequency of large cortical ischemic strokes [12]. Our meta-analysis
corroborates these results as SP in AIS patients is associated with re-
duced FIV, potentially secondary to better collateralization. Ad-
ditionally, our subgroup analysis demonstrated a favorable effect of SP
on FIV among patients with atherosclerotic strokes.
Our study has limitations. First, eligible studies included observa-
tional, small-sized cohorts that could have introduced selection bias.
Second, data on both the endpoints (FIV and collateral scores) were
unavailable in the majority of included studies. Third, statin type and
dosage were reported in only 3 of the included studies (Table 1), while
the duration of statin pretreatment was not reported in any of the in-
cluded studies. Therefore, we were not able to perform further analyses
on the duration of pretreatment, dosage or intensity of SP with the
outcomes of interest. Moreover, in the present meta-analysis, we were
unable to control for potential confounders of the collateral status, in-
cluding metabolic syndrome, hyperuricemia, age and time from stroke
onset to presentation [16,17]. Fourth, the evaluation of publication bias
using funnel plot inspection was weak, and the possibility of the pre-
sence of a small study effect cannot be excluded.
In conclusion, the present meta-analysis adds to the increasing
evidence of the beneficial effect of SP in AIS outcomes. SP is associated
with reduced infarct volumes, especially in AIS due to LAA. Future
prospective observational studies are warranted to confirm these pre-
liminary observations.
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Table 1
Study design and characteristics of included studies in our meta-analysis.
Study name Country Study design, registry Patients, N Endpoints SP+, SP- Imaging method Timing from Index Event
Cheng-Ching et al. [14] United States Retrospective 91 FIV 32, 58 DWI-MRI < 6 h
Collaterals (ASITN/SIR) 20, 34 DSA –
Chung et al. [12] South Korea Prospective, STAMINA-MRI 136 FIV 38a, 98 DWI-MRI < 7 days
Goyal et al. [11] United States Retrospective 116 FIV 53, 53 FLAIR-MRI < 14 days
Collaterals (ASITN/SIR) 56, 73 DSA –
Lee et al. [5] International Retrospective 98 Collaterals 22b, 76 DSA <8 h
Liebeskind et al. [9] International Prospective, IMS III 331 Collaterals (ASITN/SIR) 98, 178 DSA –
Safouris et al. [15] Greece Prospective 36 Collaterals (ASITN/SIR) 5, 31 DSA –
Sargento-Frietas et al. [2] Portugal Retrospective 118 Collaterals (CPC) 17, 31 DSA –
Sheth et al. [13] United States Retrospective 117 FIV 27, 89 DWI-MRI < 24 h
Collaterals (ASITN/SIR) 24, 93 DSA –
Shook et al. [6] United States Retrospective 143 FIV 38c, 105 DWI-MRI < 48 h
SP, statin pretreatment; FIV: final infarct volume; ASITN/SIR: American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional
Radiology; CPC: collateral pial circulation; MRI: magnetic resonance imaging; DWI-MRI: diffusion weighted sequence of MRI; FLAIR-MRI: fluid attenuated inversion
recovery sequence of MRI; DSA: digital subtraction angiography.
a Atorvastatin<40mg or equivalent dose (n= 22), ≥40 mg atorvastatin or equivalent dose (n=16).
b Atorvastatin> 10mg or equivalent (n=14), atorvastatin ≤10mg or equivalent (n= 8).
c Atorvastatin (n= 24, median dose 20mg), simvastatin (n= 10, median dose 20mg), pravastatin (n=3, median dose 40mg), and lovastatin (n= 1, dose
20mg).
K. Malhotra et al. Atherosclerosis 282 (2019) 75–79
77
Appendix A. Supplementary data
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.atherosclerosis.2019.01.006.
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